Skip to main content

Merck & Co., Inc.

For the period ended Feb 3, 2026. Filed Feb 3, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Feb 3, 2026 · Filed Feb 3, 2026

Use the contents to explore the available documents and sections.

MRK$146.73-0.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Table

Table 1

GAAP · GAAP
4Q254Q24% ChangeFull Year 2025Full Year 2024% Change
Sales$16,400$15,6245%$65,011$64,1681%
Costs, Expenses and Other
Cost of sales5,5513,82845%16,38215,1938%
Selling, general and administrative2,8982,8641%10,73310,816-1%
Research and development3,8864,585-15%15,78917,938-12%
Restructuring costs21351*889309*
Other (income) expense, net432126*151(24)*
Income Before Taxes3,4204,170-18%21,06719,9366%
Income Tax Provision4584252,8042,803
Net Income2,9623,745-21%18,26317,1337%
Less: Net (Loss) Income Attributable to Noncontrolling Interests(1)2916
Net Income Attributable to Merck & Co., Inc., Rahway, N.J., USA$2,963$3,743-21%$18,254$17,1177%
Earnings per Common Share Assuming Dilution$1.19$1.48-20%$7.28$6.748%
Average Shares Outstanding Assuming Dilution2,4882,5372,5072,541
Tax Rate13.4%10.2%13.3%14.1%
  • 100% or greater

MERCK & CO., INC., RAHWAY, N.J., USA

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.